NYSE:EHC - US29261A1007 - Common Stock
The current stock price of EHC is 121.76 USD. In the past month the price increased by 12.19%. In the past year, price increased by 30.85%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 16.87 | 94.52B | ||
THC | TENET HEALTHCARE CORP | 12.5 | 16.29B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 9.65 | 11.56B | ||
ENSG | ENSIGN GROUP INC/THE | 28.68 | 9.91B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 19.35 | 3.05B | ||
SGRY | SURGERY PARTNERS INC | 27.01 | 2.91B | ||
ACHC | ACADIA HEALTHCARE CO INC | 8.26 | 2.12B | ||
BKD | BROOKDALE SENIOR LIVING INC | N/A | 1.83B | ||
ARDT | ARDENT HEALTH INC | 7.09 | 1.82B | ||
PACS | PACS GROUP INC | 15.32 | 1.81B | ||
NHC | NATIONAL HEALTHCARE CORP | 16.91 | 1.76B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 12.27 | 1.61B |
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama and currently employs 23,564 full-time employees. The firm provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
ENCOMPASS HEALTH CORP
9001 Liberty Pkwy
Birmingham ALABAMA 35242 US
CEO: Mark J. Tarr
Employees: 25191
Phone: 12059677116
The current stock price of EHC is 121.76 USD. The price decreased by -1.37% in the last trading session.
The exchange symbol of ENCOMPASS HEALTH CORP is EHC and it is listed on the New York Stock Exchange, Inc. exchange.
EHC stock is listed on the New York Stock Exchange, Inc. exchange.
17 analysts have analysed EHC and the average price target is 138.47 USD. This implies a price increase of 13.72% is expected in the next year compared to the current price of 121.76. Check the ENCOMPASS HEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENCOMPASS HEALTH CORP (EHC) has a market capitalization of 12.26B USD. This makes EHC a Large Cap stock.
ENCOMPASS HEALTH CORP (EHC) currently has 25191 employees.
ENCOMPASS HEALTH CORP (EHC) has a support level at 111.53 and a resistance level at 122.51. Check the full technical report for a detailed analysis of EHC support and resistance levels.
The Revenue of ENCOMPASS HEALTH CORP (EHC) is expected to grow by 10.96% in the next year. Check the estimates tab for more information on the EHC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ENCOMPASS HEALTH CORP (EHC) has a dividend yield of 0.62%. The yearly dividend amount is currently 0.62. Check the full fundamental report for a detailed analysis of EHC dividend history, reliability and sustainability.
ENCOMPASS HEALTH CORP (EHC) will report earnings on 2025-10-27, after the market close.
The PE ratio for ENCOMPASS HEALTH CORP (EHC) is 24.5. This is based on the reported non-GAAP earnings per share of 4.97 and the current share price of 121.76 USD. Check the full fundamental report for a full analysis of the valuation metrics for EHC.
The outstanding short interest for ENCOMPASS HEALTH CORP (EHC) is 0.97% of its float. Check the ownership tab for more information on the EHC short interest.
ChartMill assigns a technical rating of 9 / 10 to EHC. When comparing the yearly performance of all stocks, EHC is one of the better performing stocks in the market, outperforming 76.31% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to EHC. While EHC has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months EHC reported a non-GAAP Earnings per Share(EPS) of 4.97. The EPS increased by 23.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 9.18% | ||
ROA | 7.67% | ||
ROE | 22.82% | ||
Debt/Equity | 1.02 |
17 analysts have analysed EHC and the average price target is 138.47 USD. This implies a price increase of 13.72% is expected in the next year compared to the current price of 121.76.
For the next year, analysts expect an EPS growth of 19.3% and a revenue growth 10.96% for EHC